Beginning Monday, 29 April 2019 12:30
End Monday, 29 April 2019 14:00
Location Boulevard Bischoffsheim 11, 1000, Brussels, Belgium
Event fees British Chamber members: €0.00 (incl. VAT)
Access Full and Patron members only

If you are a regular member or a non-member and you would like to attend, please contact wendyh@britishchamber.eu


This expert panel will look at Brexit’s implications on patients and the pharmaceutical industry in Europe and the UK. What will be the impact on research and regulation?

Panellists will discuss what measures need to be taken so that there is no reduction in patient access to safe and effective medicines. Are there any concerns or challenges that still remain unanswered?

Speakers:

First Secretary Health and Pharmaceuticals | UK Permanent Representation to EU (UKREP)

Matt Harpur is the First Secretary for Health and Pharmaceuticals at the UK Representation to the EU in Brussels. He has been a British civil servant for nearly 15 years, and has held a range of roles, most recently as Head of the EU and Multilateral team the Department of Health, working on issues relating to the World Health Organization (WHO), Global Health Security, G7 and a wide range of EU business. He has also had two stints working in Private Office and also worked on different roles relating to the life science agenda, including innovation, pharmaceutical pricing and Health Technology Assessment.

| EFPIA - European Federation of Pharmaceutical Industries and Associations

Elizabeth Kuiper is currently Executive Director for Public Affairs at EFPIA, the European Federation of Pharmaceutical Industries and Associations. In this role, she leads the advocacy and public affairs of EFPIA and maintains a strong network of contacts with policymakers and other stakeholders. She reports directly to EFPIA’s Director-General and works together closely with the other EFPIA directors active on the Brussels scene. Elizabeth previously worked as attaché at the Permanent Representation of the Netherlands to the EU, where she represented the Netherlands in EU negotiations in the field of health, pharmaceuticals and medical devices. Prior to this, Elizabeth worked as political adviser to the Minister of Health, Welfare and Sports in the Dutch cabinet Balkenende-IV, delivering special advice and support on healthcare policy related subjects. This was subsequent to her job at the Dutch Society of Surgeons. Elizabeth studied at the University of Utrecht and holds an MA in Dutch language and literature. A Dutch national, she is fluent in English, French, and German.

Public Affairs Director | EURORDIS

This event is held under the Chatham House Rule.
It aims to provide anonymity to speakers and to encourage openness and the sharing of information. It is now used throughout the world as an aid to free discussion. When a meeting, or part thereof, is held under the Chatham House Rule, participants are free to use the information received, but neither the identity nor the affiliation of the speaker(s), nor that of any other participant, may be revealed.
This event is exclusively open for members.

Sponsor this event

Contact Details:

Payment Instructions:

Wire transfer details
British Chamber of Commerce in Belgium
ING Bank: 310-1391540-64
IBAN: BE29 3101 3915 4064
SWIFT/BIC: BBRUBEBB

Not a member yet?

The British Chamber is a membership-driven organisation but is pleased to welcome non-members to sample up to two British Chamber events. Thereafter, we reserve the right to request membership for further attendance of events.

If you’d like to attend this event, please contact us and we’ll be happy to arrange a booking.